@mk_pwr's hair loss and steroid cycle claims, fact-checked
Quick answer
Androgenic alopecia results from DHT binding to hair follicle receptors in genetically susceptible individuals. Finasteride, a 5-alpha reductase inhibitor, reduces scalp DHT by approximately 70% and can slow hair loss progression. Exogenous testosterone use accelerates this process in predisposed men.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 7 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @mk_pwr's hair loss and steroid cycle claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
@mk_pwr's hair loss and steroid cycle claims, fact-checked should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "@mk_pwr's hair loss and steroid cycle claims, fact-checked" from @mk_pwr. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Androgenic alopecia results from DHT binding to hair follicle receptors in genetically susceptible individuals.
The reason this review is not generic is the source wording and the canonical claim label "trt v ina chlapcov na cykle v bec nevie pre o im mizn vlasy." In this clip, the useful excerpt is: "Väčšina chlapcov na cykle vôbec nevie prečo im miznú vlasy." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
Androgenic alopecia results from DHT binding to hair follicle receptors in genetically susceptible individuals.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Androgenic alopecia results from DHT binding to hair follicle receptors in genetically susceptible individuals. Finasteride, a 5-alpha reductase inhibitor, reduces scalp DHT by approximately 70% and can slow hair loss progression. Exogenous testosterone use accelerates this process in predisposed men.
- DHT has 2-3 times higher androgen receptor binding affinity than testosterone, not 5 times as claimed
- Estradiol does provide some protection against androgenic hair loss through prolonging growth phases
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- DHT has 2-3 times higher androgen receptor binding affinity than testosterone, not 5 times as claimed
- Estradiol does provide some protection against androgenic hair loss through prolonging growth phases
- Genetic predisposition determines hair loss susceptibility more than hormone levels alone
- Finasteride reduces scalp DHT by approximately 70% but creates complications during steroid cycles
- Maintaining physiological estradiol ranges may help minimize hair loss in steroid users
- Androgenic alopecia requires proper dermatological evaluation to distinguish from other hair loss causes
- Incomplete advice from fitness influencers shouldn't substitute for medical consultation
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What does this Instagram video actually claim?
This post from @mk_pwr tells men using anabolic steroids why they're losing hair. The creator says testosterone itself isn't the problem, but rather an enzyme called 5-alpha reductase that converts it to DHT, which he claims is "5x stronger" and destroys hair follicles.
He also argues that estrogen protects hair, so crashing estradiol levels with aromatase inhibitors (AIs) speeds up hair loss. The post promises four solutions but cuts off after the first point.
Does the DHT science check out?
The basic mechanism is correct. The enzyme 5-alpha reductase does convert testosterone to dihydrotestosterone (DHT), and DHT does cause androgenic alopecia (male pattern baldness).
But that "5x stronger" claim is misleading. DHT has about 2-3 times higher binding affinity for androgen receptors than testosterone, according to studies like Grino et al. (Endocrinology, 1990). The creator's exaggerating the potency difference.
The hair follicle destruction part is accurate though. DHT binds to receptors in genetically susceptible follicles and gradually miniaturizes them until they stop producing terminal hairs.
What about estrogen's protective effects?
This is where the creator gets something genuinely useful right. Estradiol does have protective effects on hair growth, though the mechanism isn't fully understood.
Studies like Ohnemus et al. (American Journal of Pathology, 2006) show that estrogen can prolong the anagen (growth) phase of hair cycles and may counteract some androgenic effects on follicles. When steroid users crash their estradiol with excessive AI use, they lose this protection.
The advice to keep estradiol "in normal range, not at zero" is solid harm reduction for people already using steroids.
What's missing from this advice?
The post doesn't mention that genetic predisposition matters more than anything else. You can't lose hair you weren't genetically programmed to lose, regardless of DHT levels.
It also skips over the fact that finasteride, a 5-alpha reductase inhibitor, can reduce scalp DHT by about 70% according to Drake et al. (Journal of Clinical Endocrinology & Metabolism, 1999). But finasteride during steroid cycles creates its own complications.
The incomplete nature of the post is frustrating. Promising "4 things you can do" and then cutting off feels like engagement bait rather than genuine education.
Should you trust hair loss advice from fitness influencers?
@mk_pwr demonstrates better understanding of hormone interactions than most fitness content, but incomplete advice on complex medical topics isn't helpful.
If you're experiencing hair loss, whether from steroid use or natural causes, you need proper evaluation. Dermatologists can determine if you're actually dealing with androgenic alopecia versus other causes like telogen effluvium or nutritional deficiencies.
The harm reduction approach of maintaining physiological estradiol levels is reasonable for people already committed to steroid use, but this shouldn't be interpreted as medical guidance.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
@mk_pwr · Instagram creator
74.3K views on this video
Väčšina chlapcov na cykle vôbec nevie prečo im miznú vlasy. Tu je ako to funguje 👇 Testosterón sám o sebe nie je problém. Problém je enzým 5-alfa reduktáza — ten ho konvertuje na DHT. DHT je 5x siln
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about dht has 2-3 times higher?
DHT has 2-3 times higher androgen receptor binding affinity than testosterone, not 5 times as claimed
What does the video say about estradiol does provide some protection against?
Estradiol does provide some protection against androgenic hair loss through prolonging growth phases
What does the video say about genetic predisposition determines hair loss susceptibility more than hormone levels?
Genetic predisposition determines hair loss susceptibility more than hormone levels alone
What does the video say about finasteride reduces scalp dht by approximately 70%?
Finasteride reduces scalp DHT by approximately 70% but creates complications during steroid cycles
What does the video say about maintaining physiological estradiol ranges may help minimize hair loss in?
Maintaining physiological estradiol ranges may help minimize hair loss in steroid users
What does the video say about androgenic alopecia requires proper dermatological evaluation to distinguish from other?
Androgenic alopecia requires proper dermatological evaluation to distinguish from other hair loss causes
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by @mk_pwr, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.